The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1635
October 18, 2021
View Complete Issue         Table of Contents 2019 
Treatment of Onychomycosis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Treatment of Onychomycosis
October 18, 2021 (Issue: 1635)
Onychomycosis is caused most commonly by Trichophyton rubrum or T. mentagrophytes. About 10% of all persons worldwide and 40% of those ≥60 years old are believed to have the disease. Risk factors include older age, diabetes, poor...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Treatment of Onychomycosis
Article code: 1635c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.